Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells
Sean A. Misek(Michigan State University), Richard R. Neubig(Grand Rapids Community College)
Cited by 16
Related Papers
International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
|Pharmacological Reviews|2014|236
IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels
|Nucleic Acids Research|2008|220
Inhibition of Myocardin-Related Transcription Factor/Serum Response Factor Signaling Decreases Lung Fibrosis and Promotes Mesenchymal Cell Apoptosis
|American Journal Of Pathology|2015|161
Receptor-selective Effects of Endogenous RGS3 and RGS5 to Regulate Mitogen-activated Protein Kinase Activation in Rat Vascular Smooth Muscle Cells
|Journal of Biological Chemistry|2002|126
In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis
|Journal of Nanobiotechnology|2018|40